Effect of thyroxine, pyridoxine, orphenadrine-HCl, resperine and disulfiram in periodic catatonia.
D001481:Basal Metabolism; D001831:Body Temperature; D001835:Body Weight; D002389:Catatonia / Q000188:drug therapy*; D002395:Catecholamines / Q000378:metabolism; D004221:Disulfiram / Q000627:therapeutic use*; D006801:Humans; D007273:Injections, Intramuscular; D008333:Mandelic Acids / Q000652:urine; D009647:Normetanephrine / Q000652:urine; D009966:Orphenadrine / Q000627:therapeutic use*; D010507:Periodicity; D011674:Pulse; D011736:Pyridoxine / Q000627:therapeutic use*; D012110:Reserpine / Q000627:therapeutic use*; D012890:Sleep; D013974:Thyroxine / Q000627:therapeutic use*
D002395:Catecholamines; D008333:Mandelic Acids; D009647:Normetanephrine; D012110:Reserpine; D009966:Orphenadrine; D011736:Pyridoxine; D013974:Thyroxine; D004221:Disulfiram